Phone Whasapp

MARTIN AND HARRIS LABORATORIES LTD

COMPANY NAME MARTIN AND HARRIS LABORATORIES LTD
NATURE OF BUSINESS Manufacturing of Pharmaceuticals and investment Business
ISIN NO INE03VV01015
FACE VALUE Rs.10/-
PROMOTERS Mr. AJAY GROVER
COMPANY WEBSITE www.martinharrislabs.com
YEAR OF EASTBLISHMENT 1993
REGISTERED ADDRESS Unit No. 6, LSC, S-Block, Panchsheel Park, New Delhi - 110017


BOARD OF DIRECTORS

Mr. Shanker Laad Laxman ( Director )
Mr. Vivek Manohar Padgaonkar ( Director )
Mr. Harnam Thakur Singh ( Director)

Martin and Harris Laboratories Ltd, one of India’s leading pharmaceutical companies has grown leaps and bounds to emerge as a well reputed organisation for research and manufacturing of finished dosage forms.

It offer a wide range of diversified products and state-of-the-art facilities that include flexible, cost-effective drug development and manufacturing solutions with value-added services.

Martin and Harris Laboratories has one wholly owned subsidiary: Delite Infrastructure Pvt Ltd, engaged in the business of stock investments and financial derivatives (F&O) segment.

Martin and Harris Laboratories carries out around 52% of Pharma Business and around 48% of Derivative and Investment business

The company is engaged in manufacturing of various pharmaceutical, medicinal, chemical and botanical products. Instead of its core business, it undertook the management of its funds through investment in different avenues fetching good returns, i.e. mutual funds, equity (both quoted and unquoted).

The administration of Martin and Harris Laboratories Limited is carried out by a bunch of experts which do not just have proficiency but are also quite skilled and experienced, thus making the company’s administration one of the major assets which the company has.

Products and Services offered by Martin and Harris Laboratories Limited :

  • Pharmaceutical products
  • Medical drugs
  • Allopathic
  • Clopidogrel
  • Nicorandil
  • Losartan potassium
  • Metoprolol tartrate

Financial Analysis ( ALL IN CR )

PARTICULARS 2021-22 2020-21 2019-20
REVENUE 186.31 167.7 267.3
TOTAL INCOME 212.09 335.6 296.7
EPS 175.57 442.6 31.85

ANNUAL REPORT